NEO Competitors & Alternatives
Compare NeoGenomics Inc with similar stocks in the same industry
Diagnostics & Research
NEO
Main Stock$16.98
Tradestie Score
40
Market Cap
$1.13B
Revenue Growth
0.1%
Analyst Upside
+16.1%
Top Competitors
35 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$87.07
|
$3.26B | - | 39 | Compare |
|
VCYT
Veracyte, Inc.
|
$42.31
|
$2.85B | 29.9 | 65 | Compare |
|
GRAL
GRAIL, Inc. Common Stock
|
$79.54
|
$2.24B | - | 40 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$25.99
|
$2.22B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$145.59
|
$1.77B | - | 42 | Compare |
|
NVCR
NovoCure Limited Ordinary Shares
|
$17.10
|
$1.56B | - | 42 | Compare |
|
NEOG
Neogen Corp
|
$11.95
|
$1.26B | - | 42 | Compare |
|
OPK
Opko Health Inc.
|
$1.48
|
$1.23B | - | 39 | Compare |
|
CDNA
CareDx, Inc.
|
$48.61
|
$798.40M | 22.4 | 35 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$19.90
|
$719.31M | - | 53 | Compare |
More NEO Analysis
Data updated: Aug 23, 2026 | Industry: Diagnostics & Research (SIC 8734)
35 stocks in this industry